Novartis India Ltd (NOVARTIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 333626, "name": "Novartis India", "stock_name": "Novartis India", "full_name": "Novartis India Ltd", "name_url": "stocks-analysis/novartis-india", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "921.00", "chg": -13.2, "chgp": "-1.41%", "dir": -1, "prev_price": "934.20", "mcapval": "2,267.00 Cr", "mcap": "Small Cap", "scripcode": 500672, "symbol": "NOVARTIND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE234A01025", "curr_date": "Mar 23", "curr_time": "", "bse_nse_vol": "32.31 k", "exc_status": "Active", "traded_date": "Mar 23, 2026", "traded_date_str": "2026 03 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Novartis India Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-strong-sell-3888304", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_mojoScore_3888304.png", "date": "2026-03-13 10:10:43", "description": "Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Novartis India Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-strong-sell-3863965", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovartisIndiaLt_mojoScore_3863965.png", "date": "2026-03-02 10:10:49", "description": "Novartis India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with the latest comprehensive analysis." }, { "title": "Novartis India Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3851111", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_gapup_3851111.png", "date": "2026-02-23 09:30:31", "description": "Novartis India Ltd commenced trading today with a significant gap up, opening 5.47% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start follows a series of gains over the past two days, cumulatively delivering a 22.82% return, outpacing the broader market and sector benchmarks." }, { "title": "Novartis India Surges 25.79% Despite Strong Sell Downgrade: Key Weekly Developments", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-surges-2579-despite-strong-sell-downgrade-key-weekly-developments-3850038", "imagepath": "", "date": "2026-02-21 17:14:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Feb:</strong> Stock opens at Rs.825.15, surging 4.16%</p>\n <p><strong>19 Feb:</strong> Downgrade to Strong Sell announced amid valuation and financial concerns</p>\n <p><strong>20 Feb:</strong> Intraday high of Rs.977.95 with 16.37% surge and strong gap up</p>\n <p><strong>20 Feb:</strong> Week closes at Rs.996.50, up 25.79% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.792.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"..." }, { "title": "Why is Novartis India Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-novartis-india-ltd-fallingrising-3848991", "imagepath": "", "date": "2026-02-21 01:02:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Market Outperformance Drives Investor Interest</strong></p>\n<p>Novartis India’s recent price action stands out distinctly against the backdrop of the broader market. Over the past week, the stock has gained 25.79%, vastly outperforming the Sensex’s modest 0.23% rise. This trend extends over longer periods as well, with the stock delivering a 27.67% return in the last month compared to the Sensex’s 0.77%, and a year-to-date gain of 27.92% while the benchmark index declined by 2.82%. Even on a one-year basis, Novartis India has generated a 19.17% return, doubling the Sensex’s 9.35% gain. These figures underscore the stock’s resilience and appeal amid volatile market conditions.</p>\n<p>Today’s trading session further highlighted this momentum. The stock opened with an 8.86% gap up and re..." }, { "title": "Novartis India Ltd Hits Intraday High with 16.37% Surge on 20 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-hits-intraday-high-with-1637-surge-on-20-feb-2026-3847940", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_priceRelatedfactors_3847940.png", "date": "2026-02-20 09:32:14", "description": "Novartis India Ltd recorded a robust intraday rally on 20 Feb 2026, surging to a day’s high of Rs 977.95, marking a 17.76% increase from the previous close. The stock outperformed its sector and the broader market, reflecting strong trading momentum amid a generally subdued Sensex session." }, { "title": "Novartis India Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3847932", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_gapup_3847932.png", "date": "2026-02-20 09:30:25", "description": "Novartis India Ltd (Stock ID: 333626) commenced trading on 20 Feb 2026 with a significant gap up, opening 8.86% higher than its previous close. This robust start was accompanied by an intraday high surge of 17.76%, signalling strong positive momentum in the Pharmaceuticals & Biotechnology sector amid a broader market that showed muted performance." }, { "title": "Novartis India Downgraded to Strong Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-downgraded-to-strong-sell-amid-valuation-and-financial-concerns-3846418", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_mojoScore_3846418.png", "date": "2026-02-19 08:11:15", "description": "Novartis India Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its valuation, financial trends, quality metrics, and technical indicators. The downgrade reflects concerns over the company’s expensive valuation relative to peers, deteriorating quarterly financial performance, and subdued market momentum despite some long-term growth signals." }, { "title": "Novartis India Ltd Valuation Shifts Signal Price Attractiveness Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-valuation-shifts-signal-price-attractiveness-concerns-3846203", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NovartisIndiaLt_valuationdot_3846203.png", "date": "2026-02-19 08:00:18", "description": "Novartis India Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, raising questions about its current price attractiveness. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical averages and peer benchmarks, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector." } ], "total": 216, "sid": "333626", "stock_news_url": "https://www.marketsmojo.com/news/novartis-india-333626" }, "announcements": [ { "caption": "Draft Letter of Offer", "datetime": "06-Mar-2026", "details": "Axis Capital Ltd (Manager to the Open Offer) has submitted to BSE a copy of Draft Letter of Offer to the public shareholders of Novartis India Ltd (Target Company).", "source": "BSE" }, { "caption": "Intimation Of Receipt Of Draft Letter Of Offer Received From Manager To Open Offer (Axis Capital Limited).", "datetime": "06-Mar-2026", "details": "The Company would hereby like to intimate to the Stock Exchange that the Company has received from manager to the open offer (Axis Capital Limited) the draft letter of offer dated March 05 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer", "datetime": "26-Feb-2026", "details": "The Detailed Public Statement (DPS) in relation to the open offer received by Novartis India Limited (the Company) dated Thursday February 26 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25", "dt": "2025-07-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

16 Feb: Stock opens at Rs.825.15, surging 4.16%

19 Feb: Downgrade to Strong Sell announced amid valuation and financial concerns

20 Feb: Intraday high of Rs.977.95 with 16.37% surge and strong gap up

20 Feb: Week closes at Rs.996.50, up 25.79% for the week

Week Open

Rs.792.20

Week Close

Read full news article

Why is Novartis India Ltd falling/rising?

2026-02-21 01:02:11

Strong Market Outperformance Drives Investor Interest

Novartis India’s recent price action stands out distinctly against the backdrop of the broader market. Over the past week, the stock has gained 25.79%, vastly outperforming the Sensex’s modest 0.23% rise. This trend extends over longer periods as well, with the stock delivering a 27.67% return in the last month compared to the Sensex’s 0.77%, and a year-to-date gain of 27.92% while the benchmark index declined by 2.82%. Even on a one-year basis, Novartis India has generated a 19.17% return, doubling the Sensex’s 9.35% gain. These figures underscore the stock’s resilience and appeal amid volatile market conditions.

Today’s trading session further highlighted this momentum. The stock opened with an 8.86% gap up and re...

Read full news article

Novartis India Ltd Hits Intraday High with 16.37% Surge on 20 Feb 2026

2026-02-20 09:32:14

Novartis India Ltd recorded a robust intraday rally on 20 Feb 2026, surging to a day’s high of Rs 977.95, marking a 17.76% increase from the previous close. The stock outperformed its sector and the broader market, reflecting strong trading momentum amid a generally subdued Sensex session.

Read full news article

Novartis India Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment

2026-02-20 09:30:25

Novartis India Ltd (Stock ID: 333626) commenced trading on 20 Feb 2026 with a significant gap up, opening 8.86% higher than its previous close. This robust start was accompanied by an intraday high surge of 17.76%, signalling strong positive momentum in the Pharmaceuticals & Biotechnology sector amid a broader market that showed muted performance.

Read full news article

Novartis India Downgraded to Strong Sell Amid Valuation and Financial Concerns

2026-02-19 08:11:15

Novartis India Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its valuation, financial trends, quality metrics, and technical indicators. The downgrade reflects concerns over the company’s expensive valuation relative to peers, deteriorating quarterly financial performance, and subdued market momentum despite some long-term growth signals.

Read full news article

Novartis India Ltd Valuation Shifts Signal Price Attractiveness Concerns

2026-02-19 08:00:18

Novartis India Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, raising questions about its current price attractiveness. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical averages and peer benchmarks, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News